Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-01-10T19:00:22.069Z Has data issue: false hasContentIssue false
  • English
  • Français

Differenital Behavioral and Neural Consequences of Serotonin and Catecholamine Deficiency in Depression: an Experimental Study

Published online by Cambridge University Press:  15 April 2020

G. Hasler ,
P. Homan ,
A. Neumeister ,
A.C. Nugent ,
D.S. Charney  and
W.C. Drevets
G. Hasler
Affiliation:
Dopartement of Molecular Psychiatrie, Psychiatric University Hostpital Bern, Bern, Switzerland
P. Homan
Affiliation:
Dopartement of Molecular Psychiatrie, Psychiatric University Hostpital Bern, Bern, Switzerland
A. Neumeister
Affiliation:
Molecular Imaging Program Department of Psychiatry and Radiology, New York University School of Medicine, New York, USA
A.C. Nugent
Affiliation:
Experimental Therapeutics & Pathophysiology Branch Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA
D.S. Charney
Affiliation:
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
W.C. Drevets
Affiliation:
Janssen Pharmaceuticals Research & Development, Laureate Institute for Brain Research, Tulsa/Titusville, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Psychopathological and biological markers that predict response to antidepressant drugs that selectively increase serotonin and/or chatecholaminergic neurotransmission will considerably increase the effects of currently available treatment options.

Objectives

Comparison of tryptophan depletion (TD) and catecholamine depletion (CD) regarding the pathogenesis of depressive symptoms.

Aims

To elucidate the differential symptomatology and neurocircuitry in response to reductions in serotonergic and catecholaminergic neurotransmission in subjects at high risk of depression.

Methods

Using identical neuroimaging procedures with [18F] fluorodeoxyglucose positron emission tomography after TD and CD, subjects with remitted depression were compared to healthy controls in a double-blind, randomized, crossover design.

Results

While TD induced significantly more depressed mood, sadness and hopelessness than CD, CD induced more inactivity, concentration difficulties, lassitude and somatic anxiety than TD.CD specifically increased glucose metabolism in the bilateral ventral striatum and decreased glucose metabolism in the bilateral orbitofrontal cortex, whereas TD led to a specific increase in glucose metabolism in the right prefrontal cortex and in the PCC. While we found direct associations between changes in brain metabolism and induced depressive symptoms following CD, the relationship between neural activity and symptoms was less clear after TD.

Conclusions

This study showed that serotonin and catecholamines play common and differential roles in the pathophysiology of depression. Thus, the development of psychopathological and neuronal markers predicting response to selective monoamine inhibition is feasible, and current efforts to develop antidepressants with dual and triple reuptake inhibition (serotonin, norepinephrine, dopamine) are supported by this study.

Type
Article: 1302
Information
European Psychiatry , Volume 30 , Issue S1: Abstracts of the 23rd European Congress of Psychiatry , March 2015 , pp. 1
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.